Company: RNAC
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001453687-25-000085
Chunk: 85

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part II, Item 3
Chunk 85
---
 Regulation S-K because the information (i) is not material and (ii) is the type of information that the Company both customarily and actually treats as private and confidential.

# Indicates management contract or compensatory plan.

41

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant in the capacities and on the dates indicated.

 CARTESIAN THERAPEUTICS, INC.  Date: May 8, 2025By:/s/ Carsten Brunn, Ph.D. Carsten Brunn, Ph.D. President and Chief Executive Officer, and Director(Principal Executive Officer)  Date: May 8, 2025By:/s/ Blaine Davis Blaine Davis Chief Financial Officer(Principal Financial Officer)

42